- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 1.26%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth and its peers as on 27 July, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | 11.54% | 1.26% | 0.27% | 4.41% | 11.54% | 9.32% | 21.03% | 15.53% | 22.5% | 14.79% |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -5.08% | -0.18% | 0.02% | 1.4% | -0.48% | -4.23% | 7.93% | 14.09% | 16.58% | 14% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -3.34% | 0.2% | -0.75% | 0.23% | 2.55% | 1.78% | 10.23% | 10.49% | 13.4% | 12.03% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 20.9% | 0.01% | -0.52% | 4.64% | 16.11% | 16.21% | 23.8% | 18.34% | 25.76% | 14.63% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 2.57% | -0.62% | -2.13% | -1.38% | -0.52% | 5.54% | 16.41% | 18.11% | 19.75% | 15.23% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 0.53% | -0.88% | -1.71% | -1.85% | -6.68% | 9.17% | 23.84% | 24.3% | 20% | 14.69% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -12.74% | 5.85% | -0.68% | 7.04% | 67.87% | 19.94% | -6.85% | 39.53% | 42.49% | -3.93% |
Discrete returns (monthly)
| Month | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -1.25% | 1.74% | 0.22% | -1.64% | -5.6% | 4.93% | -6.3% | 6.93% | 3.25% | 4.52% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 15.64% | 5.43% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.69% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.31% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.34% |
| ABBOTT INDIA LTD | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 5.89% |
| DIVI LABORATORIES LTD | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 5.83% |
| HEALTHCARE GLOBAL ENTERPRISES LTD | HCG (INE075I01017) | Healthcare Services | 5.39% |
| MAX HEALTHCARE INSTITUTE LTD | MAXHEALTH (INE027H01010) | Healthcare Services | 5.14% |
| CIPLA LTD | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.10% |
| APOLLO HOSPITALS ENTERPRISE LTD | APOLLOHOSP (INE437A01024) | Healthcare Services | 4.25% |
| RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 4.23% |
| MANKIND PHARMA LTD | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.57% |
| BAYER CROPSCIENCE LTD | BAYERCROP (INE462A01022) | Fertilizers & Agrochemicals | 3.51% |
| DR REDDYS LABORATORIES LTD | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 3.45% |
| LUPIN LTD | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 3.18% |
| FORTIS HEALTHCARE LTD | FORTIS (INE061F01013) | Healthcare Services | 3.17% |
| METROPOLIS HEALTHCARE LTD | METROPOLIS (INE112L01020) | Healthcare Services | 3.02% |
| DR. LAL PATH LABS LTD | LALPATHLAB (INE600L01024) | Healthcare Services | 2.69% |
| SYNGENE INTERNATIONAL LTD | SYNGENE (INE398R01022) | Healthcare Services | 2.64% |
| SAI LIFE SCIENCES LTD | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.58% |
| ALKEM LABORATORIES LTD | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.45% |
| J.B.CHEMICALS & PHARMACEUTICALS LTD | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 2.40% |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 2.14% |
| NEULAND LABORATORIES LTD | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 2.08% |
| AJANTA PHARMA LTD | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 2.04% |
| GLOBAL HEALTH LTD | MEDANTA (INE474Q01031) | Healthcare Services | 2.01% |
| FDC LTD | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 1.84% |
| SANOFI INDIA LTD | SANOFI (INE058A01010) | Pharmaceuticals & Biotechnology | 1.70% |
| VIJAYA DIAGNOSTIC CENTRE LTD | VIJAYA (INE043W01024) | Healthcare Services | 1.41% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | KIMS (INE967H01025) | Healthcare Services | 1.34% |
| AUROBINDO PHARMA LTD | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 1.20% |
| TORRENT PHARMACEUTICALS LTD | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 1.10% |
| CORONA REMEDIES LTD | CORONA (INE02ZQ01018) | Pharmaceuticals & Biotechnology | 0.75% |
| PROCTER & GAMBLE HEALTH LTD | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 0.70% |
| PI INDUSTRIES LTD | PIIND (INE603J01030) | Fertilizers & Agrochemicals | 0.63% |
| HDFC LIFE INSURANCE CO. LTD | HDFCLIFE (INE795G01014) | Insurance | 0.62% |
| TATA CHEMICALS LTD | TATACHEM (INE092A01019) | Chemicals & Petrochemicals | 0.50% |
| SUMITOMO CHEMICAL INDIA LTD | SUMICHEM (INE258G01013) | Fertilizers & Agrochemicals | 0.39% |
| JUBILANT PHARMOVA LTD | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.34% |
| DR. AGARWALS HEALTH CARE LTD | AGARWALEYE (INE943P01029) | Healthcare Services | 0.07% |
Portfolio data is as on date 31 March, 2026
NAV history
Tata India Pharma & Healthcare Fund-Direct Plan-Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 27 July, 2026 | 39.3993 | 1.26% |
| 24 July, 2026 | 38.9085 | -0.18% |
| 23 July, 2026 | 38.9805 | -0.51% |
| 22 July, 2026 | 39.1819 | -0.66% |
| 21 July, 2026 | 39.4414 | 0.37% |
| 20 July, 2026 | 39.2946 | 0.83% |
| 17 July, 2026 | 38.9711 | -0.91% |
| 16 July, 2026 | 39.3274 | 0.27% |
| 15 July, 2026 | 39.2197 | 0.21% |
| 14 July, 2026 | 39.1382 | 0.51% |
| 13 July, 2026 | 38.9403 | 0.13% |
| 10 July, 2026 | 38.8913 | 0.57% |
| 9 July, 2026 | 38.6714 | 1.41% |
| 8 July, 2026 | 38.1353 | -1.03% |
| 7 July, 2026 | 38.5320 | -0.75% |
| 6 July, 2026 | 38.8230 | 0.36% |
| 3 July, 2026 | 38.6849 | 1% |
| 2 July, 2026 | 38.3002 | 0.49% |
| 1 July, 2026 | 38.1140 | -0.03% |
| 30 June, 2026 | 38.1238 | 0.93% |
| 29 June, 2026 | 37.7732 | 0.1% |
| 25 June, 2026 | 37.7357 | -0.26% |
| 24 June, 2026 | 37.8322 | 0.3% |
| 23 June, 2026 | 37.7205 | 0.06% |
| 22 June, 2026 | 37.6975 | 0.76% |
| 19 June, 2026 | 37.4133 | 0.38% |
| 18 June, 2026 | 37.2707 | 0.73% |
| 17 June, 2026 | 37.0015 | -0.01% |
| 16 June, 2026 | 37.0061 | -0.05% |
| 15 June, 2026 | 37.0237 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The latest NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth is 39.3993 as on 27 July, 2026.What are YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 11.54% as on 27 July, 2026.What are 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 9.32% as on 27 July, 2026.What are 3 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 3 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 21.03% as on 27 July, 2026.What are 5 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 5 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 15.53% as on 27 July, 2026.What are 10 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 10 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 15.53% as on 27 July, 2026.